Semaglutide begins working in your body within days of the first dose, but the effects you actually notice, like reduced appetite or lower blood sugar, typically take one to three weeks to become obvious. Measurable weight loss and significant blood sugar improvements build over several months as your dose gradually increases.
The reason for this gap between “working in your body” and “feeling different” comes down to how the medication is prescribed. You start on a low dose designed to let your body adjust, not to produce dramatic results. The timeline looks different depending on whether you’re taking semaglutide for blood sugar control or weight loss, so here’s what to realistically expect at each stage.
What Happens in the First Week
After your first injection, semaglutide reaches its peak concentration in your bloodstream within one to three days. The standard starting dose of 0.25 mg per week is intentionally low. It’s not really a treatment dose. It exists to give your digestive system time to adapt and minimize nausea, which is the most common side effect early on.
During this first week, the medication is pharmacologically active. It slows stomach emptying and signals fullness to your brain. Some people notice subtle changes in appetite or how quickly they feel full at meals within the first few days. Cleveland Clinic notes that the effects of each weekly injection typically reach maximum strength around 72 hours after the shot. But plenty of people feel nothing different at this stage, and that’s normal. The dose is simply too low for many people to perceive a change.
Weeks 1 Through 4: The Adjustment Phase
You’ll stay on the 0.25 mg dose for the first four weeks on both the diabetes version (Ozempic) and the weight management version (Wegovy). During this window, your body reaches what pharmacologists call steady state, meaning the drug has built up to a consistent level rather than spiking and dipping with each dose. According to FDA clinical pharmacology data, this steady-state concentration takes four to five weeks of regular dosing to establish.
In practical terms, weeks one through four often bring small, subtle changes. You might notice slightly smaller portions feel satisfying, or that post-meal blood sugar readings dip a bit compared to your baseline. But these shifts are often so gradual that you won’t see them without actively tracking. Some people report no noticeable difference at all during this phase, which doesn’t mean the medication isn’t working.
When Appetite Suppression Kicks In
Reduced hunger is usually the first effect people clearly notice, and for most, it becomes apparent somewhere between the first and fourth week. The variation is wide. A small number of people feel dramatically less hungry within days of their first injection. Others don’t experience a real shift in appetite until they move up to a higher dose at week five or later.
This isn’t just a placebo-friendly observation. Semaglutide mimics a gut hormone that acts on appetite centers in the brain, and the strength of that signal scales with the dose. At 0.25 mg, the signal is modest. When your dose increases to 0.5 mg (typically around week five), many people describe a more definitive change: less food noise, fewer cravings, and feeling full sooner. If you haven’t noticed much appetite change in the first month, the dose increase is often where things click.
Blood Sugar Improvements
If you’re taking semaglutide for type 2 diabetes, blood sugar responds on a slightly different timeline than appetite. Small improvements in post-meal glucose readings can appear within the first one to two weeks, but fasting glucose levels tend to drop more noticeably once you’re on 0.5 mg or higher, around weeks four through eight.
The longer-term marker that doctors track is HbA1c, which reflects your average blood sugar over roughly three months. In clinical trials, participants starting with an HbA1c of 8% saw it drop to around 7% by week eight. That’s a meaningful one-point reduction in just two months. More substantial HbA1c improvements continue to build over the following months as doses increase and the medication’s effects compound.
The pattern here is consistent: early weeks bring small, incremental changes. The more significant shifts in glucose control arrive after you’ve been on a therapeutic dose (0.5 mg or above) for several weeks.
Weight Loss Milestones
Visible weight loss is the slowest effect to materialize, partly because semaglutide is titrated gradually. With Wegovy (the weight management formulation), the dose increases every four weeks: 0.25 mg, then 0.5 mg, then 1 mg, then 1.7 mg, and finally up to a maximum maintenance dose. This means you won’t reach your full treatment dose until roughly month four or five.
Most people see their first few pounds come off during weeks four through eight, once the dose reaches 0.5 mg and appetite suppression becomes more consistent. Weight loss then accelerates as doses continue to climb. Clinical trials showed that the majority of weight loss occurs over the first six to nine months of treatment, with results continuing to accumulate through about 15 to 17 months before plateauing.
A realistic expectation for the first month is modest: perhaps one to three pounds, sometimes more, sometimes nothing visible on the scale yet. By three months, most people have lost enough to notice changes in how clothing fits. The largest percentage of body weight loss typically happens between months three and nine, when you’re on or approaching your maintenance dose and the cumulative calorie deficit adds up.
Why the Slow Titration Matters
It’s tempting to view the first month as wasted time, but the gradual dose increase serves a real purpose. Semaglutide’s most common side effects (nausea, vomiting, diarrhea, constipation) are dose-dependent. Starting low and increasing slowly gives your gastrointestinal system time to adapt, which significantly reduces the chance you’ll have side effects severe enough to make you want to stop the medication entirely.
Skipping ahead or starting at a higher dose doesn’t just increase nausea. It can cause vomiting severe enough to lead to dehydration, and it’s one of the more common reasons people discontinue treatment prematurely. The slow start is a tradeoff: delayed results in exchange for a much higher likelihood of tolerating the medication long enough to get those results.
What “Not Working” Actually Looks Like
Because semaglutide takes months to reach full effect, it’s too early to judge whether the medication is working for you during the first four to six weeks. The real assessment window begins after you’ve been on a stable therapeutic dose (at minimum 0.5 mg, but often 1 mg or higher) for at least four to eight weeks.
If you’ve been on 1 mg or above for two months and have noticed no change in appetite, blood sugar, or weight, that’s a meaningful data point worth discussing with your prescriber. Some people are lower responders and benefit from dose increases. Others may have factors like concurrent medications, thyroid conditions, or metabolic adaptations that blunt the response. But making that call at week two or three on a starter dose would be premature. The medication genuinely hasn’t had a fair chance yet at that point.